Literature DB >> 17594917

Brucellosis in the middle East: a persistent medical, socioeconomic and political issue.

G Pappas1, Z A Memish.   

Abstract

Human brucellosis remains endemic in the majority of Middle Eastern countries, accounting for tens of thousands of new annual cases, despite partly successful efforts at disease control. In the Middle East, more pronouncedly than elsewhere, brucellosis exhibits significant socioeconomic and political correlations, including population literacy and distribution, and development of health networks. Currently, Middle Eastern countries, having a vast pool of human cases, generate important information regarding the disease's clinical manifestations, diagnosis, and treatment. Given the socioeconomic framework of brucellosis endemicity, specific approaches allowing for rapid, cost-effective diagnosis, and efficient cost-effective therapy should be pursued. Overall, attempts at controlling disease without altering the socioeconomic and political correlations may prove futile, unfortunately projecting similar fates for attempts related to more important communicable diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594917     DOI: 10.1179/joc.2007.19.3.243

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  10 in total

1.  Treatment of brucellosis: a systematic review of studies in recent twenty years.

Authors:  Seyed Mohammad Alavi; Leila Alavi
Journal:  Caspian J Intern Med       Date:  2013

2.  Comparison of two multiple-locus variable-number tandem-repeat analysis methods for molecular strain typing of human Brucella melitensis isolates from the Middle East.

Authors:  Rebekah V Tiller; Barun K De; Marie Boshra; Lynn Y Huynh; Matthew N Van Ert; David M Wagner; John Klena; T S Mohsen; S S El-Shafie; Paul Keim; Alex R Hoffmaster; Patricia P Wilkins; Guillermo Pimentel
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

3.  Rethinking "One Health" through Brucellosis: ethics, boundaries and politics.

Authors:  Barak Hermesh; Anat Rosenthal; Nadav Davidovitch
Journal:  Monash Bioeth Rev       Date:  2019-10

Review 4.  Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.

Authors:  Julián Solís García del Pozo; Javier Solera
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

Review 5.  Retrospective and prospective perspectives on zoonotic brucellosis.

Authors:  Edgardo Moreno
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

Review 6.  Brucellosis in the Middle East: Current situation and a pathway forward.

Authors:  Ramin Bagheri Nejad; Rosina C Krecek; Omar H Khalaf; Nabil Hailat; Angela M Arenas-Gamboa
Journal:  PLoS Negl Trop Dis       Date:  2020-05-21

7.  Interferon-γ receptor-1 gene promoter polymorphisms and susceptibility for brucellosis in Makkah region.

Authors:  A B Ismael; A Mergani; A Salim; S Mostafa; I Alkafaween
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

8.  Prevalence and surveillance of tuberculosis in Yemen from 2006 to 2018.

Authors:  Wadee Abdullah Al-Shehari; Yi-An Yin; Xinyang Wang; Ying Wang; Haobo Sun; Yingmei Fu; Fengmin Zhang
Journal:  Epidemiol Infect       Date:  2022-07-20       Impact factor: 4.434

9.  African Lineage Brucella melitensis Isolates from Omani Livestock.

Authors:  Jeffrey T Foster; Faith M Walker; Brandy D Rannals; M Hammad Hussain; Kevin P Drees; Rebekah V Tiller; Alex R Hoffmaster; Abdulmajeed Al-Rawahi; Paul Keim; Muhammad Saqib
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

10.  Brucella Seroprevalence in a High-Risk Population in Greece: A Cross-Sectional Study.

Authors:  Panagiotis Andriopoulos; Dimitrios Floros; Natalia Gioti; Anargiros Mariolis; Andrea Paola Rojas Gil; Maria Tsironi
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-12-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.